After graduating from veterinary school in Toulouse (France) in 1984, Dr. Olivry became one of the managing partners of the Frégis specialty clinic in Paris. In 1991, he moved to the USA to complete a residency in dermatology and a PhD in comparative pathology at the University of California, Davis. He became board-certified by both the ECVD in 1993 and the ACVD in 1995 and is now an emeritus diplomate for both colleges. Dr. Olivry spent 28 years as a clinician-scientist in immunodermatology at the North Carolina State University College of Veterinary Medicine (NCSU, 1994-2022) and is now a Professor Emeritus at that institution. In November 2022, he became Head of Research & Development at Nextmune, a multinational animal health company headquartered in Stockholm, Sweden. From 1999 to 2004, he was the Chair of the ACVD and International Task Force on Canine Atopic Dermatitis, and from 2008 to 2009, President of the European College of Veterinary Dermatology. Dr. Olivry has authored over 380 articles and book chapters, and he has delivered hundreds of lectures to veterinary and medical audiences worldwide. For more than two decades, he has researched the mechanisms and treatments of atopic dermatitis, food allergy, and itch in dogs, and characterized multiple new autoimmune skin diseases in small and large animal species. He pioneered the use of evidence-based medicine in veterinary dermatology. He now focuses on veterinary molecular allergology.